Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.
Aflatoxin exposure and hepatitis B virus infection have been implicated as major risk factors for primary hepatocellular carcinoma (PHC) in high-incidence regions of the world. Investigations using the assay of aflatoxin bound to peripheral blood albumin have shown that exposure can occur throughout the life span of the individual, including during the perinatal period, in high-incidence areas such as The Gambia, Senegal, Kenya, and The People's Republic of China. The possibility of measuring aflatoxin exposure at the individual level permits an investigation of the putative mechanisms of interaction of this carcinogen with HBV in the etiopathogenesis of PHC. Animal models, e.g., Pekin duck and HBV-transgenic mice, have also been used to study these questions, and the available data are reviewed.
International Agency for Research on Cancer, Lyon, France.
C P
CP
Wild
L A
LA
Jansen
L
L
Cova
R
R
Montesano
D016604:Aflatoxin B1 / Q000378:metabolism; D000348:Aflatoxins / Q000009:adverse effects* / Q000378:metabolism; D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000209:etiology*; D003043:Cocarcinogenesis; D004247:DNA / Q000378:metabolism; D018736:DNA Adducts; D004812:Epidemiologic Methods; D006509:Hepatitis B / Q000150:complications*; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology / Q000209:etiology*; D008114:Liver Neoplasms, Experimental / Q000209:etiology; D051379:Mice; D008822:Mice, Transgenic; D012709:Serum Albumin / Q000187:drug effects / Q000378:metabolism
D000348:Aflatoxins; D018736:DNA Adducts; D012709:Serum Albumin; C072611:aflatoxin B1-DNA adduct; D004247:DNA; D016604:Aflatoxin B1